Industry
Biotechnology
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Loading...
Open
25.23
Mkt cap
15B
Volume
3.8M
High
25.88
P/E Ratio
10.12
52-wk high
31.66
Low
25.10
Div yield
0.03
52-wk low
25.10
Portfolio Pulse from Benzinga Newsdesk
September 03, 2024 | 9:14 pm
Portfolio Pulse from Avi Kapoor
August 16, 2024 | 1:28 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 11:10 am
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 2:45 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 11:03 am
Portfolio Pulse from Avi Kapoor
June 12, 2024 | 1:15 pm
Portfolio Pulse from Benzinga Newsdesk
June 03, 2024 | 9:18 pm
Portfolio Pulse from Benzinga Newsdesk
June 03, 2024 | 3:50 pm
Portfolio Pulse from Vandana Singh
May 28, 2024 | 5:00 pm
Portfolio Pulse from Benzinga Newsdesk
May 28, 2024 | 11:17 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.